The German health care system at the crossroads.
作者信息
vd Schulenburg J M
出版信息
Health Econ. 1994 Sep-Oct;3(5):301-3. doi: 10.1002/hec.4730030503.
PMID:7827645
Abstract
摘要
相似文献
1
The German health care system at the crossroads.
Health Econ. 1994 Sep-Oct;3(5):301-3. doi: 10.1002/hec.4730030503.
2
The German health system. Lessons for reform in the United States.
Arch Intern Med. 1997 Jan 27;157(2):155-60.
3
[Reform options in the GKV].
Chirurg. 2000 Jul;71(7):suppl 166-70.
4
German health care--towards universal access. An overview of the principles of access and benefits.
J Contemp Health Law Policy. 2002 Fall;18(3):673-83.
5
The context for health reform in the United Kingdom, Sweden, Germany, and the United States.
Health Policy. 1997 Sep;41 Suppl:S9-26. doi: 10.1016/s0168-8510(97)00050-x.
6
The German health care system: structure and changes.
J Clin Anesth. 1994 May-Jun;6(3):252-62. doi: 10.1016/0952-8180(94)90069-8.
7
The German health care system and health care reform.
Health Policy. 1998 Feb;43(2):171-94. doi: 10.1016/s0168-8510(97)00096-1.
8
9
Revolution in the German health care system.
J Clin Anesth. 1994 May-Jun;6(3):250-1. doi: 10.1016/0952-8180(94)90068-x.
10
Commission recommends reform of German health care. Proposed deep cuts in services and higher tax contributions highly unpopular with public.
Lancet. 2003 Oct 25;362(9393):1388. doi: 10.1016/s0140-6736(03)14683-1.
引用本文的文献
1
Prescription data as a tool in pharmacotherapy audit (I). General considerations.
Pharm World Sci. 1999 Apr;21(2):80-4. doi: 10.1023/a:1008617832536.
2
Customising an international disease management model to the needs of individual countries. Application to upper gastrointestinal disease.
Pharmacoeconomics. 1998;14 Suppl 2:39-56. doi: 10.2165/00019053-199814002-00005.
3
Strategies to improve the cost effectiveness of general practitioner prescribing. An international perspective.
Pharmacoeconomics. 1997 Sep;12(3):307-11. doi: 10.2165/00019053-199712030-00003.
4
Pricing and reimbursement of pharmaceuticals. A new culture for the community pharmacist.
Pharm World Sci. 1998 Jun;20(3):107-12. doi: 10.1023/a:1008651106315.
5
Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry.
BMJ. 1996 Jul 6;313(7048):33-5. doi: 10.1136/bmj.313.7048.33.
6
Lessons from international experience in controlling pharmaceutical expenditure. II: Influencing doctors.
BMJ. 1996 Jun 15;312(7045):1525-7. doi: 10.1136/bmj.312.7045.1525.
Zotero 插件